var data={"title":"Albendazole: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Albendazole: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5575?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=albendazole-patient-drug-information\" class=\"drug drug_patient\">see &quot;Albendazole: Patient drug information&quot;</a> and <a href=\"topic.htm?path=albendazole-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Albendazole: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130833\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Albenza</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130867\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Anthelmintic</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130835\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Neurocysticercosis:</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">&lt;60 kg: 15 mg/kg/day in 2 divided doses (maximum: 800 mg/day) for 8 to 30 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">&ge;60 kg: 800 mg/day in 2 divided doses for 8 to 30 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Note:</b> Give concurrent anticonvulsant and corticosteroid therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Hydatid:</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">&lt;60 kg: 15 mg/kg/day in 2 divided doses (maximum: 800 mg/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">&ge;60 kg: 800 mg/day in 2 divided doses</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Note:</b> Administer dose for three 28-day cycles with a 14-day drug-free interval in between each cycle.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Ancylostoma caninum</i>, <i>Ascaris lumbricoides </i> (roundworm), <i>Ancylostoma duodenale</i> (hookworm), and <i>Necator americanus </i> (hookworm) (off-label use):</b> Oral: 400 mg as a single dose (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Clonorchis sinensis </i> (Chinese liver fluke) or Opisthorchis viverrini (Southeast Asian liver fluke) (off-label use):</b> Oral: 10 mg/kg/day for 7 days (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Cutaneous larva migrans (off-label use):</b> Oral: 400 mg once daily for 3 days (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Cysticercus</i> (off-label use):</b> Oral: 15 mg/kg/day (maximum: 800 mg/day) in 2 divided doses for 8 to 30 days; may be repeated as necessary (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Echinococcus granulosus</i> (tapeworm) (off-label use):</b> Oral: 15 mg/kg/day (maximum: 800 mg/day) in 2 divided doses for 1 to 6 months (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Enterobius vermicularis </i> (pinworm) (off-label use):</b> Oral: 400 mg as a single dose; repeat in 2 weeks (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Giardia duodenalis</i> (giardiasis) (off-label use):</b> Oral: 400 mg once daily for 5 days (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Gnathostoma spinigerum</i> (off-label use):</b> Oral: 800 mg/day in 2 divided doses for 21 days (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Gongylonemiasis (off-label use):</b> Oral: 400 mg once daily for 3 days (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Microsporidiosis:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">Immunocompetent patients:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">Disseminated (off-label use): 800 mg/day in 2 divided doses (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">Intestinal (<i>E. intestinalis</i>) (off-label use): 800 mg/day in 2 divided doses for 21 days (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">Ocular (off-label use): 800 mg/day in 2 divided doses, in combination with topical fumagillin (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">Immunocompromised (HIV-positive) patients</p>\n    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">Disseminated or intestinal infection (other than <i>Enterocytozoon bieneusi</i> or <i>V. corneae</i>) (off-label use): 800 mg/day in 2 divided doses; continue until CD4 count &gt;200 cells/mm<sup>3</sup> for &gt;6 months after initiation of  antiretroviral therapy (DHHS [OI Adults 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">Ocular (off-label use): 800 mg/day in 2 divided doses, in combination with topical fumagillin; continue until resolution of ocular symptoms and until CD4 count &gt;200 cells/mm<sup>3</sup> for &gt;6 months after initiation of antiretroviral therapy (DHHS [OI Adults 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Oesophagostomum bifurcum</i> (off-label use):</b> Oral: 400 mg as a single dose (Ziem 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>\n        <i>Trichinella spiralis</i> (Trichinellosis) (off-label use):</b> Oral: 800 mg/day in 2 divided doses for 8 to 14 days plus corticosteroids for severe symptoms (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">\n      <b>Visceral larva migrans (toxocariasis) (off-label use):</b> Oral: 800 mg/day in 2 divided doses for 5 days (Parasitic Infections 2013)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130850\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=albendazole-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Albendazole: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Neurocysticercosis:</b> Children and Adolescents: Oral: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Hydatid:</b> Children and Adolescents: Oral: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n      <b>\n        <span style=\"text-decoration: underline\">Off-label uses:</span></b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Cysticercus</i> (off-label use):</b> Pediatric: Oral: 15 mg/kg/day (maximum: 800 mg/day) in 2 divided doses for 8 to 30 days; may be repeated as necessary (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Giardia duodenalis</i> (giardiasis) (off-label use):</b> Children and Adolescents: Oral: 10 mg/kg/day for 5 days (Yereli 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Microsporidiosis (other than <i>Enterocytozoon bieneuesi</i> or <i>V. corneae</i>), disseminated or intestinal infection, HIV-positive (off-label use):</b> Infants, Children, and Adolescents: 15 mg/kg/day (maximum: 800 mg/day) in 2 divided doses continued until immune reconstitution after cART initiation (DHHS [OI Children] 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Microsporidiosis, intestinal infection (immunocompetent) (off-label use):</b> Infants &ge;6 months and Children: 15 mg/kg/day in 2 divided doses for 7 days (Tremoulet 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">\n      <b>Additional pediatric off-label uses: </b>     Refer to adult dosing: <i>Ancylostoma caninum</i>, <i>Ascaris lumbricoides</i> (roundworm), <i>Ancylostoma duodenale</i> (hookworm), <i>Clonorchis sinensis</i> (Chinese liver fluke), cutaneous larva migrans, <i>Echinococcus granulosus</i> (tapeworm), <i>Enterobius vermicularis</i> (pinworm), <i>Gnathostoma spinigerum</i>, gongylonemiasis, <i>Necator americanus</i> (hookworm), <i>Oesophagostomum bifurcum</i>, <i>Opisthorchis viverrini</i> (Southeast Asian liver fluke), <i>Trichinella spiralis</i> (Trichinellosis), visceral larva migrans (toxocariasis)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130836\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15671330\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling (has not been studied). However, the need for adjustment not likely since albendazole is primarily eliminated by hepatic metabolism. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15671331\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in manufacturer's labeling. However, patients with underlying liver disease may be more at risk for adverse effects.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130812\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Albenza: 200 mg [contains saccharin sodium]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130799\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130814\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Administer with a high-fat meal if treating a systemic infection (to increase absorption). Administration on an empty stomach may be appropriate for treating an intraluminal infection with no systemic involvement (Lange 1988). If patients have difficulty swallowing, tablets may be crushed or chewed, then swallowed with a drink of water.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130813\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Hydatid disease:</b> Treatment of cystic hydatid disease of the liver, lung, and peritoneum caused by the larval form of the dog tapeworm, <i>Echinococcus granulosus</i>.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Neurocysticercosis:</b> Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, <i>Taenia solium</i>.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25708398\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Microsporidiosis in HIV-infected patients  (adolescents and adults)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3195081\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Albenza may be confused with Aplenzin, Relenza</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Albenza [US] may be confused with Avanza brand name for mirtazapine [Australia]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130806\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">&gt;10%: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Central nervous system: Headache (neurocysticercosis: 11%; hydatid: 1%)  </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Hepatic: Increased liver enzymes (hydatid: 16%; neurocysticercosis: &lt;1%) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">1% to 10%: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Central nervous system: Increased intracranial pressure (&le;2%), dizziness (&le;1%), vertigo (&le;1%), meningism (1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Dermatologic: Alopecia (&lt;1% to 2%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Gastrointestinal: Abdominal pain (&le;6%), nausea and vomiting (4% to 6%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Miscellaneous: Fever (&le;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">&lt;1%, postmarketing, and/or case reports: Acute hepatic failure, acute renal failure, agranulocytosis, aplastic anemia, erythema multiforme, granulocytopenia, hepatitis, hypersensitivity reaction, leukopenia, neutropenia, pancytopenia, skin rash, Stevens-Johnson syndrome, thrombocytopenia, urticaria </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130817\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to albendazole, benzimidazoles, or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130803\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Bone marrow suppression: Agranulocytosis, aplastic anemia, granulocytopenia, leukopenia, and pancytopenia have occurred leading to fatalities (rare); use with caution in patients with hepatic impairment (more susceptible to hematologic toxicity).  Discontinue therapy in all patients who develop clinically significant decreases in blood cell counts.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Transaminase elevations: Reversible elevations in hepatic enzymes have been reported. Patients with abnormal LFTs and hepatic echinococcosis are at an increased risk of hepatotoxicity. Discontinue therapy if LFT elevations are &gt;2 times the upper limit of normal; may consider restarting treatment (with frequent monitoring of LFTs) when hepatic enzymes return to pretreatment values. Discontinue therapy if hepatic enzymes are significantly increased.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Neurocysticercosis: Appropriate use: Corticosteroids should be administered before or upon initiation of albendazole therapy to minimize inflammatory reactions and prevent increased intracranial pressure. Anticonvulsant therapy should be used concurrently to prevent seizures. If retinal lesions exist, weigh risk of further retinal damage due to albendazole-induced inflammatory changes to the retinal lesion vs benefit of disease treatment.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130860\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Substrate</b> of CYP1A2 (minor), CYP3A4 (minor); <b>Note:</b> Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130807\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9371&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Aminoquinolines (Antimalarial): May decrease the serum concentration of Anthelmintics.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CarBAMazepine: May decrease serum concentrations of the active metabolite(s) of Albendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Grapefruit Juice: May increase serum concentrations of the active metabolite(s) of Albendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">PHENobarbital: May decrease serum concentrations of the active metabolite(s) of Albendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phenytoin: May decrease serum concentrations of the active metabolite(s) of Albendazole.<i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130829\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;display:inline\">Albendazole serum levels may be increased if taken with a fatty meal (increases the oral bioavailability by up to 5 times). Management: Should be administered with a high-fat meal when treating systemic infections.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130808\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130820\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events were observed in animal reproduction studies. Albendazole should not be used during pregnancy, if at all possible. The manufacturer recommends a pregnancy test prior to therapy in women of reproductive potential. Women should be advised to avoid pregnancy during and for at least 1 month following therapy. Discontinue if pregnancy occurs during treatment. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20519483\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Albendazole excretion into breast milk was studied following a single oral 400 mg dose in breast-feeding women 2 weeks to 6 months postpartum (n=33). Mean albendazole concentrations 6 hours after the dose were 63.7 &plusmn; 11.9 ng/mL (maternal serum) and 31.9 &plusmn; 9.2 ng/mL (milk). An active and inactive metabolite was also detected in breast milk (Abdel-tawab, 2009). The manufacturer recommends that caution be exercised when administering albendazole to nursing women. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130810\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">LFTs and CBC with differential at start of each 28-day cycle and every 2 weeks during therapy (more frequent monitoring for patients with liver disease); ophthalmic exam for retinal lesions (patients with neurocysticercosis); pregnancy test</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130802\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Active metabolite, albendazole sulfoxide, causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired, and desecratory substances accumulate intracellulary. ATP production decreases causing energy depletion, immobilization, and worm death.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130816\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Note:</b> In pediatric patients (6-13 years), pharmacokinetic values were reported to be similar to adult data.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Poor from the GI tract; may increase up to 5 times when administered with a fatty meal </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Widely distributed throughout the body including urine, bile, liver, cyst wall, cyst fluid, and CSF  </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Protein binding: 70% </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Hepatic; extensive first-pass effect; pathways include rapid sulfoxidation to active metabolite (albendazole sulfoxide [major]), hydrolysis, and oxidation </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: 8 to 12 hours (albendazole sulfoxide) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak, serum: 2 to 5 hours for the metabolite</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (&lt;1% as active metabolite); feces</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130819\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Albenza Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">200 mg (2): $438.77</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F130822\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Abentel (BD, CN, TH);</li>\n      <li>ABZ (IN, ZW);</li>\n      <li>Acure (PK);</li>\n      <li>Adazol (EC);</li>\n      <li>Albatel (TH);</li>\n      <li>Alben (BR);</li>\n      <li>Alben-VC (TH);</li>\n      <li>Albenda (AE, BH, KW, LB, QA, SA);</li>\n      <li>Albentel (PE);</li>\n      <li>Albentox (LK);</li>\n      <li>Albenzol (EC);</li>\n      <li>Albex (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LK, LY, OM, QA, SA, SY, VN, YE);</li>\n      <li>Albezole (IN);</li>\n      <li>Albi (KR);</li>\n      <li>Aldaben (BD);</li>\n      <li>Aldazol (PH);</li>\n      <li>Alfuca (TH);</li>\n      <li>Allbacom (KR);</li>\n      <li>Almex (MY);</li>\n      <li>Alminth (IN);</li>\n      <li>Alzental (AE, BH, CY, EG, ET, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SG, SY, YE);</li>\n      <li>Alzol (TH);</li>\n      <li>Andazol (TR);</li>\n      <li>Anhelmin (UA);</li>\n      <li>Ascarol (EC);</li>\n      <li>Ben A (BD);</li>\n      <li>Bendex (ET);</li>\n      <li>Bendex-400 (ZA);</li>\n      <li>Benzol (PH);</li>\n      <li>Bruzol (CR, DO, GT, HN, MX, NI, PA, SV);</li>\n      <li>Buxol (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>CB-400 (TH);</li>\n      <li>Ceprazol (CL);</li>\n      <li>Ciclopar (CO);</li>\n      <li>Cystazole (JO);</li>\n      <li>Dalben (HR);</li>\n      <li>Daxol Plus (PY);</li>\n      <li>Dazole (LK);</li>\n      <li>Digezanol (MX);</li>\n      <li>Emanthal (IN);</li>\n      <li>Eskasole (MX);</li>\n      <li>Eskazole (AT, AU, DE, ES, GB, IL, JP, NL, NZ);</li>\n      <li>Estazole (LK);</li>\n      <li>Fintel (PE);</li>\n      <li>Frantel (VN);</li>\n      <li>Gascop (MX);</li>\n      <li>Gloalbendazole (KR);</li>\n      <li>Helmiben (UY);</li>\n      <li>Helmidazole (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Hyemex (PH);</li>\n      <li>Labenda (TH);</li>\n      <li>Lokaben (LK);</li>\n      <li>Lomsin (MX);</li>\n      <li>Lurdex (MX);</li>\n      <li>Mebenix (BR);</li>\n      <li>Nemozole (IN, ZW);</li>\n      <li>Olworm (LK);</li>\n      <li>Ovis (ET);</li>\n      <li>Oxal (MX);</li>\n      <li>Oxarmin (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Pantex (PY);</li>\n      <li>Paranthil (ZA);</li>\n      <li>Parhel (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Rex (KR);</li>\n      <li>Rotopar (EC);</li>\n      <li>Sintel (BD);</li>\n      <li>Sioban (IN);</li>\n      <li>Temizol (PY);</li>\n      <li>Thelban (MY);</li>\n      <li>Unizol (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Valbazen Vet (NO);</li>\n      <li>Vastus (AR);</li>\n      <li>Vemizol (MY);</li>\n      <li>Vermin Plus (MX);</li>\n      <li>Vetoben (TH);</li>\n      <li>Vormil (UA);</li>\n      <li>Wormed (ZW);</li>\n      <li>Zeben (TH);</li>\n      <li>Zela (TH);</li>\n      <li>Zendal (MY);</li>\n      <li>Zental (RO);</li>\n      <li>Zentel (AE, AU, BB, BF, BG, BH, BJ, BM, BR, BS, BZ, CH, CI, CL, CN, CO, CR, CY, CZ, EC, EG, ET, FR, GH, GM, GN, GR, GT, GY, HN, IQ, IR, IT, JM, JO, KE, KR, KW, LB, LR, LY, MA, ML, MR, MU, MW, MX, MY, NE, NG, NI, OM, PA, PE, PL, PR, PT, QA, SA, SC, SD, SG, SI, SK, SL, SN, SR, SV, SY, TH, TN, TT, TZ, UA, UG, VE, VN, YE, ZA, ZM, ZW);</li>\n      <li>Zestaval (TR, ZW)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Albenza (albendazole) chewable tablets [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; December 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Albenza (albendazole) tablets [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; June 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Abdel-tawab AM, Bradley M, Ghazaly EA, et al, &quot;Albendazole and its Metabolites in the Breast Milk of Lactating Women Following a Single Oral Dose of Albendazole,&quot;<i> Br J Clin Pharmacol</i>, 2009, 68(5):737-42.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/19916998/pubmed\" target=\"_blank\" id=\"19916998\">19916998</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Baird RA, Wiebe S, Zunt JR, et al, &ldquo;Evidence-Based Guideline: Treatment of Parenchymal Neurocysticercosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology,&rdquo; <i>Neurology</i>, 2013, 80(15):1424-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/23568997/pubmed\" target=\"_blank\" id=\"23568997\">23568997</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bethony J, Brooker S, Albonico M, et al, &ldquo;Soil-Transmitted Helminth Infections: Ascariasis, Trichuriasis, and Hookworm,&rdquo; <i>Lancet</i>, 2006, 367(9521):1521-32.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/16679166/pubmed\" target=\"_blank\" id=\"16679166\">16679166</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Del Brutto OH, Roos KL, Coffey CS, et al, &ldquo;Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel,&rdquo; <i>Ann Intern Med</i>, 2006, 145(1):43-51.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/16818928/pubmed\" target=\"_blank\" id=\"16818928\">16818928</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    de Silva N, Guyatt H, and Bundy D, &ldquo;Anthelmintics. A Comparative Review of Their Clinical Pharmacology,&rdquo; <i>Drugs</i>, 1997, 53(5):769-88.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/9129865/pubmed\" target=\"_blank\" id=\"9129865\">9129865</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Parasites - Cysticercosis. Available at <a href=\"http://www.cdc.gov/parasites/cysticercosis/health_professionals/index.html#drugs\" target=\"_blank\">http://www.cdc.gov/parasites/cysticercosis/health_professionals/index.html#drugs</a>. Updated April 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    DHHS Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Department of Health and Human Services. November 2013. Available at <a href=\"http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf\" target=\"_blank\">http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf</a>.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    HHS Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. September 2015. Available at <a href=\"http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf\" target=\"_blank\">http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf</a>. Accessed October 8, 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &ldquo;Drugs for Parasitic Infections,&rdquo; <i>Med Lett Drugs Ther</i>, 2013, 11(suppl):e1-31.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Garcia HH, Gilman RH, Horton J, et al, &ldquo;Albendazole therapy for neurocysticercosis: A Prospective Double-Blind Trial Comparing 7 Versus 14 Days of Treatment,&rdquo; <i>Neurology</i>, 1997, 48(5):1421-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/9153484/pubmed\" target=\"_blank\" id=\"9153484\">9153484</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Garcia HH, Pretell EJ, Gilman RH, &ldquo;A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis,&rdquo; <i>N Engl J Med</i>, 2004, 350(3):249-58.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/14724304/pubmed\" target=\"_blank\" id=\"14724304\">14724304</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hawk MW, Shahlaie K, Kim KD, and Theis JH, &ldquo;Neurocysticercosis: A Review,&rdquo; <i>Surg Neurol</i>, 2005, 63(2):123-32.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15680651/pubmed\" target=\"_blank\" id=\"15680651\">15680651</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"3396623\"></a>Lange H, Eggers R, Bircher J. Increased systemic availability of albendazole when taken with a fatty meal. <i>Eur J Clin Pharmacol</i>. 1988;34(3):315-317.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/3396623/pubmed\" target=\"_blank\" id=\"3396623\">3396623</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Liu LX and Weller PF, &ldquo;Antiparasitic Drugs,&rdquo; <i>N Engl J Med</i>, 1996, 334(18):1178-84.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/8602186/pubmed\" target=\"_blank\" id=\"8602186\">8602186</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Smego, RA, Bhatti S, Khaliq AA, et al, &ldquo;Percutaneous Aspiration-Injection-Reaspiration Drainage Plus Albendazole or Mebendazole for Hepatic Cystic Echinococcosis: A Meta-Analysis,&rdquo; <i>Clin Infect Dis</i>, 2003, 37(8):1073-83.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/14523772/pubmed\" target=\"_blank\" id=\"14523772\">14523772</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tremoulet AH, Avila-Aquero ML, Paris MM, Canas-Coto A, Ulloa-Gutierrez R, Faingezicht I. Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. <i>Pediatr Inf Dis J</i>. 2004;23(10):915-918.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15602190/pubmed\" target=\"_blank\" id=\"15602190\">15602190</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wilson ME, Lorente CA, Allen JE, et al, &ldquo;Gongylonema Infection of the Mouth in a Resident of Cambridge, Massachusetts,&rdquo; <i>Clin Infect Dis</i>, 2001, 32(9):1378-80.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/11303277/pubmed\" target=\"_blank\" id=\"11303277\">11303277</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Yereli K, Balcio&#287;lu IC, Ertan P, et al, &quot;Albendazole as an Alternative Therapeutic Agent for Childhood Giardiasis in Turkey,&quot; <i>Clin Microbiol Infect</i>, 2004, 10(6):527-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15191380/pubmed\" target=\"_blank\" id=\"15191380\">15191380</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ziem JB, Kettenis IM, Bayita A, et al, &quot;The Short-Term Impact of Albendazole Treatment on <i>Oesophagostomum bifurcum</i> and Hookworm Infections in Northern Ghana,&quot; <i>Ann Trop Med Parasitol</i>, 2004, 98(4):385-90.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15228719/pubmed\" target=\"_blank\" id=\"15228719\">15228719</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9371 Version 120.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F130833\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F130867\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F130835\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F130850\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F130836\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F15671330\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F15671331\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F130812\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F130799\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F130814\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F130813\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25708398\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F3195081\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F130806\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F130817\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F130803\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F130860\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F130807\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F130829\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F130808\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F130820\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F20519483\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F130810\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F130802\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F130816\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F130819\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F130822\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9371|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=albendazole-patient-drug-information\" class=\"drug drug_patient\">Albendazole: Patient drug information</a></li><li><a href=\"topic.htm?path=albendazole-pediatric-drug-information\" class=\"drug drug_pediatric\">Albendazole: Pediatric drug information</a></li></ul></div></div>","javascript":null}